Display options
Cite
Joshi A, Varthakavi P, Chadha M, et al. A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. 2013;2013:397814doi: 10.1155/2013/397814.
Joshi, A., Varthakavi, P., Chadha, M., & Bhagwat, N. (2013). A study of bone mineral density and its determinants in type 1 diabetes mellitus. Journal of osteoporosis, 2013397814. https://doi.org/10.1155/2013/397814
Joshi, Ameya, et al. "A study of bone mineral density and its determinants in type 1 diabetes mellitus." Journal of osteoporosis vol. 2013 (2013): 397814. doi: https://doi.org/10.1155/2013/397814
Joshi A, Varthakavi P, Chadha M, Bhagwat N. A study of bone mineral density and its determinants in type 1 diabetes mellitus. J Osteoporos. 2013;2013:397814. doi: 10.1155/2013/397814. Epub 2013 Mar 31. PMID: 23607045; PMCID: PMC3628496.
Copy Download .nbib Format: NLM
Share it on

J Osteoporos. 2013;2013:397814. doi: 10.1155/2013/397814. Epub 2013 Mar 31.

A study of bone mineral density and its determinants in type 1 diabetes mellitus.

Journal of osteoporosis

Ameya Joshi, Premlata Varthakavi, Manoj Chadha, Nikhil Bhagwat

Affiliations

  1. Departmnent of Endocrinology, Topiwala National Medical College & BYL Nair Hospital, Mumbai 400008, India.

PMID: 23607045 PMCID: PMC3628496 DOI: 10.1155/2013/397814

Abstract

Type 1 diabetes mellitus (T1DM) has been inconsistently associated with low bone mineral density (BMD) and increased fracture risk. 86 consecutive T1DM cases and 140 unrelated age and sex matched healthy nondiabetic controls were included in the study. After history and examination, BMD and body composition were assessed by dual energy X-ray absorptiometry (DXA). Serum samples were analyzed for calcium, phosphorus, albumin, creatinine, alkaline phosphatase, 25 (OH) vitamin D3, intact parathormone (PTH) levels (both cases and controls) and HbA1c, antimicrosomal and IgA tissue transglutaminase (IgA TTG) antibodies, cortisol, follicle stimulating hormone (FSH), testosterone, sex hormone binding globulin (SHBG), tetraiodothyronine (T4), thyroid stimulating hormone (TSH), growth hormone (GH), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP3) (cases only). T1DM cases had a lower BMD as compared to controls at both total body (TB) and lumbar spine (LS) (P < 0.05). Patients with celiac autoimmunity (CA) had significantly, lower BMD as compared to age, sex, and body mass index (BMI) matched T1DM controls. Linear regression analysis showed that low BMD in T1DM patients was associated with poor glycaemic control, lower IGF-1 levels, less physical activity (in total population as well as in male and female subgroups), and lower body fat percentage (in females) and higher alkaline phosphatase level (in males) (P < 0.05).

References

  1. J Bone Miner Res. 2012 May;27(5):1206-14 - PubMed
  2. Acta Paediatr. 1998 Mar;87(3):244-9 - PubMed
  3. Int J Pediatr Endocrinol. 2010;2010:161285 - PubMed
  4. Osteoporos Int. 2009 Aug;20(8):1401-6 - PubMed
  5. Arch Dis Child. 2002 Dec;87(6):495-8 - PubMed
  6. J Pediatr. 2007 May;150(5):461-6 - PubMed
  7. Curr Opin Endocrinol Diabetes Obes. 2007 Dec;14(6):429-35 - PubMed
  8. J Clin Endocrinol Metab. 2006 Oct;91(10):3947-53 - PubMed
  9. Osteoporos Int. 2007 Apr;18(4):427-44 - PubMed
  10. Diabetes Care. 2008 Sep;31(9):1729-35 - PubMed
  11. Am J Epidemiol. 2007 Sep 1;166(5):495-505 - PubMed
  12. Osteoporos Int. 2009 Jun;20(6):923-33 - PubMed
  13. J Endocrinol. 1998 Nov;159(2):297-306 - PubMed
  14. Diabetologia. 2006 May;49(5):863-71 - PubMed
  15. Diabetes Care. 1999 May;22(5):827-31 - PubMed
  16. Public Health Nutr. 2006 Sep;9(6):755-62 - PubMed
  17. Osteoporos Int. 2000;11(5):455-9 - PubMed

Publication Types